Haya Lorberboum-Galski

This inventor holds 8 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Bioblast Pharma Ltd., Other. Active years: 2000-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haya Lorberboum-Galski. Retrieved from https://idiyas.com/inventor/haya-lorberboum-galski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 1)

% Patents Active = 50.0

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 58(Granted Patents)

Location History:

Jersusalem, IL (2010)
Jerusalem, IL (2000 - 2019)

Company Filing History:

6 out of 915

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.

1 out of 834,570

Other

patents

Years Active: 2000-2019

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10287331 - Mitochondrial proteins constructs and uses thereof (2019-05-14),

2. 8912147 - Mitochondrial proteins constructs and uses thereof (2014-12-16),

3. 7740853 - Fcepsilon-pe chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the same (2010-06-22),

4. 7704506 - Fcε-PE chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the same (2010-04-27),

5. 6933271 - Chimeric toxins for targeted therapy (2005-08-23),

6. 6645490 - Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities (2003-11-11),

7. 6531133 - Pseudomonas exotoxin-myelin basic protein chimeric proteins (2003-03-11),

8. 6140066 - Methods of cancer diagnosis using a chimeric toxin (2000-10-31),

Profile summary based on public USPTO records.